NYSE:DLB - Dolby Laboratories Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $79.00
  • Forecasted Upside: -20.83 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$99.78
▲ +0.17 (0.17%)
1 month | 3 months | 12 months
Get New Dolby Laboratories Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DLB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DLB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$79.00
▼ -20.83% Downside Potential
This price target is based on 4 analysts offering 12 month price targets for Dolby Laboratories in the last 3 months. The average price target is $79.00, with a high forecast of $89.00 and a low forecast of $65.00. The average price target represents a -20.83% upside from the last price of $99.78.
Buy
The current consensus among 4 polled investment analysts is to buy stock in Dolby Laboratories. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/28/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/25/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/24/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/20/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
3/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/25/2021Tigress FinancialReiterated RatingBuyLow
i
1/29/2021B. RileyBoost Price TargetNeutral$79.00 ➝ $89.00High
i
1/26/2021Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
i
Rating by J. Goss at Barrington Research
1/4/2021Barrington ResearchDowngradeOutperform ➝ Market PerformN/A
i
11/13/2020B. RileyBoost Price TargetNeutral$73.00 ➝ $79.00High
i
Rating by E. Wold at B. Riley
8/5/2020Barrington ResearchBoost Price TargetOutperform$70.00 ➝ $83.00Low
i
8/4/2020B. RileyBoost Price TargetNeutral$72.00 ➝ $73.00High
i
Rating by E. Wold at B. Riley
6/24/2020B. RileyDowngradeBuy ➝ Neutral$68.00 ➝ $72.00High
i
Rating by Eric Wold at B. Riley
5/29/2020B. RileyReiterated RatingBuy$68.00Low
i
Rating by Eric Wold at B. Riley
5/5/2020JPMorgan Chase & Co.Lower Price TargetOverweight$66.00 ➝ $65.00High
i
5/5/2020B. RileyLower Price TargetBuy$71.00 ➝ $68.00High
i
Rating by Eric Wold at B. Riley
4/15/2020B. RileyReiterated RatingBuy$60.00 ➝ $71.00Low
i
Rating by Eric Wold at B. Riley
3/26/2020Barrington ResearchLower Price TargetPositive ➝ Outperform$85.00 ➝ $70.00Medium
i
Rating by James Goss at Barrington Research
3/24/2020B. RileyUpgradeNeutral ➝ Buy$57.00 ➝ $60.00High
i
Rating by Eric Wold at B. Riley
3/18/2020B. RileyLower Price TargetNeutral$71.00 ➝ $57.00High
i
Rating by E. Wold at B. Riley
3/13/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$66.00 ➝ $66.00High
i
3/9/2020Tigress FinancialReiterated RatingBuyHigh
i
Rating by Ivan Feinseth at Tigress Financial
1/30/2020Barrington ResearchReiterated RatingBuyLow
i
Rating by James Goss at Barrington Research
1/10/2020B. RileyDowngradeBuy ➝ Neutral$73.00Low
i
Rating by E. Wold at B. Riley
11/21/2019Barrington ResearchReiterated RatingBuy$85.00Low
i
Rating by James Goss at Barrington Research
11/11/2019Dougherty & CoReiterated RatingBuyMedium
i
Rating by S. Frankel at Dougherty & Co
11/11/2019B. RileyUpgradeNeutral ➝ Buy$73.00Medium
i
Rating by E. Wold at B. Riley
9/18/2019Tigress FinancialReiterated RatingBuyLow
i
8/2/2019William BlairReiterated RatingBuyLow
i
Rating by Ralph Schackart at William Blair
8/2/2019B. RileyUpgradeNeutral ➝ BuyHigh
i
Rating by Eric Wold at B. Riley
8/2/2019B. RileyReiterated RatingNeutral ➝ Neutral$67.00 ➝ $73.00High
i
Rating by Eric Wold at B. Riley
6/13/2019B. RileySet Price TargetHold$67.00Low
i
Rating by Eric Wold at B. Riley
1/31/2019Barrington ResearchReiterated RatingBuy$85.00High
i
12/4/2018B. RileySet Price TargetHold$67.00High
i
Rating by Eric Wold at B. Riley
10/25/2018B. RileyLower Price TargetNeutral$69.00 ➝ $63.00High
i
10/22/2018R. F. LaffertyLower Price TargetBuy ➝ Buy$81.00 ➝ $80.00Low
i
9/7/2018Tigress FinancialReiterated RatingBuyLow
i
9/5/2018R. F. LaffertyInitiated CoverageBuy$81.00Low
i
7/26/2018Barrington ResearchReiterated RatingBuy$78.00High
i
7/26/2018B. RileyBoost Price TargetNeutral$61.00 ➝ $69.00High
i
5/1/2018Barrington ResearchReiterated RatingBuy$78.00Low
i
1/25/2018B. RileyDowngradeHold$63.00High
i
Rating by E. Wold at B. Riley
1/25/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$63.00 ➝ $70.00Medium
i
1/16/2018B. RileyDowngradeBuy ➝ Neutral$63.00 ➝ $63.00High
i
Rating by Eric Wold at B. Riley
10/26/2017B. RileyReiterated RatingBuy$65.50N/A
i
Rating by Eric Wold at B. Riley
10/19/2017B. RileySet Price TargetBuy$61.50 ➝ $66.00N/A
i
Rating by Eric Wold at B. Riley
9/14/2017B. RileyReiterated RatingBuy$61.50Low
i
Rating by Eric Wold at B. Riley
9/13/2017Dougherty & CoReiterated RatingBuy$63.00Low
i
9/13/2017Piper Jaffray CompaniesReiterated RatingHold$49.00 ➝ $52.00High
i
8/23/2017B. RileyReiterated RatingDLB ($61.50Low
i
Rating by Eric Wold at B. Riley
8/18/2017B. RileyReiterated RatingDLB ($61.50Low
i
Rating by Eric Wold at B. Riley
8/18/2017B. RileySet Price TargetBuy$62.00Low
i
Rating by Eric Wold at B. Riley
7/28/2017B. RileyReiterated RatingBuy$61.50Low
i
Rating by E. Wold at B. Riley
7/22/2017B. RileyUpgradeBuy$61.50Low
i
Rating by E. Wold at B. Riley
7/17/2017B. RileyUpgradeNeutral ➝ Buy$57.00 ➝ $61.50High
i
Rating by E. Wold at B. Riley
4/30/2017B. RileyReiterated RatingNeutral$57.00Medium
i
4/25/2017B. RileyReiterated RatingNeutral$52.00 ➝ $57.00Low
i
1/28/2017B. RileyInitiated CoverageNeutral$52.00N/A
i
1/26/2017Piper Jaffray CompaniesReiterated RatingHoldN/A
i
1/23/2017B. RileyReiterated RatingNeutral$49.00N/A
i
Rating by Eric Wold at B. Riley
1/20/2017Piper Jaffray CompaniesReiterated RatingHold$46.00N/A
i
11/1/2016B. RileyReiterated RatingNeutral$49.00N/A
i
Rating by Eric Wold at B. Riley
10/27/2016B. RileyReiterated RatingNeutral$49.00N/A
i
Rating by Eric Wold at B. Riley
10/27/2016Barrington ResearchUpgradeMarket Perform ➝ OutperformN/A
i
Rating by J. Goss at Barrington Research
10/21/2016B. RileyInitiated CoverageNeutral$50.00N/A
i
Rating by Eric Wold at B. Riley
10/4/2016JPMorgan Chase & Co.Initiated CoverageNeutral$51.00N/A
i
Rating by Paul Coster at JPMorgan Chase & Co.
8/2/2016B. RileyReiterated RatingNeutral$50.00N/A
i
Rating by Eric Wold at B. Riley
7/28/2016B. RileySet Price TargetHold$50.00N/A
i
Rating by Eric Wold at B. Riley
7/28/2016Dougherty & CoBoost Price TargetBuy$54.00 ➝ $57.00N/A
i
Rating by Steve Frankel at Dougherty & Co
7/25/2016B. RileyReiterated RatingNeutral$46.00N/A
i
5/3/2016B. RileyReiterated RatingNeutral$46.00N/A
i
5/1/2016Piper Jaffray CompaniesReiterated RatingNeutral$43.00N/A
i
4/28/2016B. RileyReiterated RatingNeutral$46.00N/A
i
4/25/2016Dougherty & CoReiterated RatingBuy$38.00 ➝ $46.00N/A
i
Rating by Steve Frankel at Dougherty & Co
(Data available from 4/21/2016 forward)
Dolby Laboratories logo
Dolby Laboratoties, Inc. designs and manufactures audio and imaging products for the cinema, television, broadcast, and entertainment industries. Its products include Cinema Imaging, Cinema Audio, Dolby Conference Phone, Dolby Voice Room, and Other Products. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.
Read More

Today's Range

Now: $99.78
$99.58
$99.90

50 Day Range

MA: $99.93
$96.09
$103.19

52 Week Range

Now: $99.78
$52.13
$103.88

Volume

189 shs

Average Volume

497,405 shs

Market Capitalization

$10.14 billion

P/E Ratio

44.35

Dividend Yield

0.87%

Beta

0.89

Frequently Asked Questions

What sell-side analysts currently cover shares of Dolby Laboratories?

The following Wall Street analysts have issued stock ratings on Dolby Laboratories in the last year: B. Riley, Barrington Research, JPMorgan Chase & Co., TheStreet, Tigress Financial, and Zacks Investment Research.
View the latest analyst ratings for DLB.

What is the current price target for Dolby Laboratories?

3 Wall Street analysts have set twelve-month price targets for Dolby Laboratories in the last year. Their average twelve-month price target is $79.00, suggesting a possible downside of 20.7%. B. Riley has the highest price target set, predicting DLB will reach $89.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $65.00 for Dolby Laboratories in the next year.
View the latest price targets for DLB.

What is the current consensus analyst rating for Dolby Laboratories?

Dolby Laboratories currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DLB will outperform the market and that investors should add to their positions of Dolby Laboratories.
View the latest ratings for DLB.

What other companies compete with Dolby Laboratories?

Other companies that are similar to Dolby Laboratories include Amphenol, Corning, Littelfuse, Vishay Intertechnology and Rogers.

How do I contact Dolby Laboratories' investor relations team?

Dolby Laboratories' physical mailing address is 1275 MARKET STREET, SAN FRANCISCO CA, 94103. The electronics maker's listed phone number is (415) 558-0200 and its investor relations email address is [email protected] The official website for Dolby Laboratories is www.dolby.com.